SS-31 Chicago — Chicagoland Peptides

Research guides

• Elamipretide (SS-31): What the Published Mitochondrial Research ReportsA research-library overview of elamipretide (SS-31), a synthetic mitochondria-targeting tetrapeptide described as binding cardiolipin in the inner mitochondrial membrane [1]. The literature summarised here is largely in vitro and animal work spanning cardiac, skeletal muscle, neural, renal, pulmonary and ocular models [3][5][6][10][15][16][17][18], alongside narrative reviews that note clinical trials have been conducted and that rigorous human data for non-approved peptide use remain limited [1][20].
• SS-31 (Elamipretide): What the Published Research ReportsA research-library overview of SS-31 (elamipretide), a mitochondria-targeted tetrapeptide, summarising what cell-based, animal, and review literature reports about its cardiolipin interaction, bioenergetic effects, and organ-specific preclinical models.
• SS-31 (Elamipretide) Animal Study Design: Models, Controls, and Endpoints in the Published LiteratureA research-framing overview of how published preclinical studies of SS-31 (elamipretide) were designed — the animal models used, comparator arms, treatment windows, and mitochondrial and functional endpoints measured — alongside the in vitro work that informs those designs.